TETRAPHASE PHARMACEUTICALS I - COM (TTPH)

CUSIP: 88165N105

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
23,639,637
Share change
+704,771
Total reported value
$26,708,287
Price per share
$1.13
Number of holders
82
Value change
-$423,167
Number of buys
38
Number of sells
32

Quarterly Holders Quick Answers

What is CUSIP 88165N105?
CUSIP 88165N105 identifies TTPH - TETRAPHASE PHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TETRAPHASE PHARMACEUTICALS I - COM (TTPH) as of Q4 2018

As of 31 Dec 2018, TETRAPHASE PHARMACEUTICALS I - COM (TTPH) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,639,637 shares. The largest 10 holders included BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Vanguard Group Inc, DEUTSCHE BANK AG\, Tekla Capital Management LLC, 683 Capital Management, LLC, TWO SIGMA INVESTMENTS, LP, and NORTHERN TRUST CORP. This page lists 82 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.